RRC ID 1199
著者 Horiguchi-Yamada J, Fukumi S, Saito S, Nakayama R, Iwase S, Yamada H.
タイトル DNA topoisomerase II inhibitor, etoposide, induces p21WAF1/CIP1 through down-regulation of c-Myc in K562 cells.
ジャーナル Anticancer Res
Abstract BACKGROUND:Anticancer agents modulate gene expression and these changes are essential for tumor cell killing. To investigate the mechanism by which etoposide acts as an anticancer agent, the relationship between p21WAF1/CIP1 (p21) and c-Myc was studied.
MATERIALS AND METHODS:K562 cells with and without ectopic c-Myc expression were studied. Apoptosis was detected using propidium iodide and Hoechst 33342 double staining. The c-Myc and p21 levels were studied by RT-PCR and immunoblot. The p21 promoter (from -205 to +67) was investigated by the luciferase reporter gene assay.
RESULTS:Ectopic c-Myc-expressing K562 (K562/c-Myc) cells showed more extensive apoptosis than K562 cells after continuous exposure to 200 microM etoposide for 24 hours. During this treatment, p21 expression was not observed in K562/c-Myc cells, and the expression of c-Myc and p21 was mutually exclusive. Etoposide activated the p21 promoter in a concentration-dependent manner, and etoposide-induced luciferase activity was suppressed by co-transfection of c-Myc.
CONCLUSION:p21 promoter activity was repressed by c-Myc in proliferating K562 cells, and detoposide-induced down-regulation of c-Myc released this suppression, resulting in the induction of p21.
巻・号 22(6C)
ページ 3827-32
公開日 2002-1-1
PMID 12553001
MeSH Antineoplastic Agents, Phytogenic / pharmacology* Apoptosis / drug effects Base Sequence Cyclin-Dependent Kinase Inhibitor p21 Cyclins / antagonists & inhibitors Cyclins / biosynthesis* Cyclins / genetics Down-Regulation / drug effects Enzyme Inhibitors / pharmacology* Etoposide / pharmacology* Gene Expression Regulation, Neoplastic / drug effects* Genes, myc / drug effects Genes, myc / genetics Humans K562 Cells / drug effects* K562 Cells / metabolism K562 Cells / physiology Molecular Sequence Data Promoter Regions, Genetic Proto-Oncogene Proteins c-myc / biosynthesis* Proto-Oncogene Proteins c-myc / genetics Topoisomerase II Inhibitors* Transcription, Genetic / drug effects
IF 1.994
引用数 10
WOS 分野 ONCOLOGY
リソース情報
ヒト・動物細胞 K562(RCB0027)